Results 11 to 20 of about 2,459,862 (252)

Thrombin–antithrombin III complex tests

Journal of Orthopaedic Surgery, 2017
Purpose: Patients with fractures of the pelvis and/or lower extremities are at a high risk of developing postoperative venous thromboembolism (VTE). The purpose of this study was to determine whether the thrombin–antithrombin III complex (TAT) tests ...
Sang Yang Lee, Takahiro Niikura, Takashi Iwakura, Yoshitada Sakai, Ryosuke Kuroda, Masahiro Kurosaka   +5 more
doaj   +2 more sources

Antithrombin III Protects Against Contrast-Induced Nephropathy

EBioMedicine, 2017
We previously reported that insufficiency of antithrombin III (ATIII), the major anti-coagulation molecule in vivo, exacerbated renal ischemia-reperfusion injury in animal models and possibly humans. In the present study, we investigated the relationship
Zeyuan Lu, Dongsheng Cheng, Jianyong Yin, Rui Wu, Guangyuan Zhang, Qing Zhao, Niansong Wang, Feng Wang, Mingyu Liang   +8 more
doaj   +2 more sources

Antithrombin-III [PDF]

Definitions, 2020
openaire   +2 more sources

Antithrombin III [PDF]

Springer Reference Medizin, 2019
openaire   +2 more sources

SerpinC1/Antithrombin III in kidney-related diseases

Clinical science, 2017
The gene SerpinC1 encodes a serine protease inhibitor named antithrombin III (ATIII). This protease demonstrates both anticoagulant and anti-inflammatory action.
Zeyuan Lu, Feng Wang, Mingyu Liang
semanticscholar   +1 more source

Relationship between Antithrombin III Activity and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

COPD, 2022
We aimed to explore the role of antithrombin III (AT-III) activity in diagnosing patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and chronic bronchitis, and its relationship with all-cause mortality of AECOPD patients ...
Shuling Zhang, Xiaoguang Li, Haili Ma, Mengpei Zhu, Yuequan Zhou, Qianqian Zhang, Hongxing Peng   +6 more
doaj   +1 more source

Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths [PDF]

, 2011
Background: Acceleration of chronic diseases, particularly cardiovascular disease, may increase long-term mortality after community-acquired pneumonia (CAP), but underlying mechanisms are unknown. Persistence of the prothrombotic state that occurs during
A. Murat Kaynar, AM Toschke, CN Serhan, CR Meier, DC Cowper, Derek C. Angus, EA Halm, EB Milbrandt, F Balkwill, FL Brancati, Florian Mayr, GD Lowe, Gina D'Angelo, GT Kinasewitz, GW Waterer, H Putter, I Koivula, J Bordon, J Kasal, J Kelly, JA Kellum, JL Hsu, JL Vincent, John A. Kellum, JU Hedlund, Kaikobad Irani, L Smeeth, Lisa Weissfeld, ME Charlson, MJ Fine, MJ Pencina, MM Doody, MM Levy, MM Samama, NM Sathiakumar, Patricia T. Bozza, PM Ridker, PR Woodhouse, S Yende, S Yende, Sachin Yende, SE Epstein, Tammy Young, TC Clayton, TT Keller, TT Keller, V Kaplan, VF Corrales-Medina, WA Knaus, WB Kannel   +49 more
core   +9 more sources

Antithrombin III: Plasma Activity and Reference Range Among Nigerian Blood Donors

Nigerian Postgraduate Medical Journal, 2015
Background: Diagnosis of antithrombin III (ATIII) deficiency as a common cause of thrombophilia is primarily based on the determination of antithrombin levels in plasma using a functional activity assay or an immunological assay, but local reference ...
Vincent Oluseye Osunkalu, Okezie Obasi Kanu, Felix Ngwuli   +2 more
doaj   +1 more source

Quantification of antithrombin isoform proportions in plasma samples of healthy subjects, sepsis patients, and in antithrombin concentrates [PDF]

, 2002
Antithrombin (AT) circulates in plasma in two isoforms, AT-alpha (90-95%) and AT-beta (5-10%). AT isoform proportions were measured in plasma samples of 17 healthy subjects and 26 posttraumatic or postoperative septic patients, as well as in 4 ...
Donges, R., Hoffmann, J. N., Inthorn, D., Jochum, M., Muhlbayer, D., Romisch, J., Stauss, H.   +6 more
core   +1 more source

Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double‐blind, controlled trial

Hepatology Research, 2017
Portal vein thrombosis (PVT) is one of the most critical disorders in liver disease patients. These patients have the imbalance of coagulation and coagulation inhibition resulting from decreased levels of coagulation inhibitory factors, such as protein C,
H. Hidaka, S. Kokubu, Takahiro Sato, S. Katsushima, N. Izumi, T. Igura, Shingo Asahara, K. Notsumata, Y. Osaki, K. Tsuji, H. Kawanaka, T. Akahoshi, S. Hirota, S. Matsutani   +13 more
semanticscholar   +1 more source